COVID-19 early treatment: real-time analysis of 927 studies

Share Tweet

All studies Early treatment Mortality Early treatment mortality Recent studies

Aspirin Bamlanivimab Bromhexine Budesonide Casirivimab/i.. Colchicine Conv. Plasma Curcumin Favipiravir Fluvoxamine Hydroxychloro.. Iota-carragee.. Ivermectin Melatonin Molnupiravir Nigella Sativa Nitazoxanide Povidone-Iod.. Probiotics Proxalutamide Quercetin Remdesivir Sotrovimab Vitamin A Vitamin C Vitamin D Zinc

Analysis of the efficacy of early treatments for COVID-19. Treatments do not replace vaccines and other measures. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage.

https://c19early.com/

This site has charts and links to many studies and articles regarding the various treatments. Data and facts.